Vertex Pharmaceuticals Inc (VRTX): Shareholders' Equity
$18.67B
As of 2025-12-31
$20.25B
As of 2026-06-30
+10.3%
3-year compound annual growth
+16.5%
5-year compound annual growth
+34.8%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $18.67B | +13.7% | 2026-02-13, Balance as of period end |
| 2024-12-31 | $16.41B | -6.7% | 2026-02-13, Balance as of period end |
| 2023-12-31 | $17.58B | +26.4% | 2026-02-13, Balance as of period end |
| 2022-12-31 | $13.91B | +37.7% | 2025-02-13, Balance as of period end |
| 2021-12-31 | $10.10B | +16.3% | 2024-02-15, Balance as of period end |
| 2020-12-31 | $8.69B | +42.8% | 2023-02-10, Balance as of period end |
| 2019-12-31 | $6.09B | +37.2% | 2022-02-09, Balance as of period end |
| 2018-12-31 | $4.44B | +118.6% | 2019-02-13, Balance as of period end |
| 2017-12-31 | $2.03B | +75.4% | 2019-02-13, Balance as of period end |
| 2016-12-31 | $1.16B | +23.0% | 2018-02-15, Balance as of period end |
| 2015-12-31 | $939.97M | -12.6% | 2017-02-23, Balance as of period end |
| 2014-12-31 | $1.08B | -20.7% | 2016-02-16, Balance as of period end |
| 2013-12-31 | $1.36B | +35.8% | 2015-02-13, Balance as of period end |
| 2012-12-31 | $999.18M | +27.0% | 2014-02-11, Balance as of period end |
| 2011-12-31 | $786.84M | +56.1% | 2013-03-01, Balance as of period end |
| 2010-12-31 | $503.97M | -54.0% | 2012-02-22, Balance as of period end |
| 2009-12-31 | $1.10B | +359.0% | 2012-02-22, Balance as of period end |
| 2008-12-31 | $238.87M | n/a | 2011-02-17, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $18.67B | +13.7% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $377.00M | n/m |
| Viatris Inc (VTRS) | 2025-12-31 | $14.71B | -21.1% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $31.26B | +6.5% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $3.33B | -30.2% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $7.91B | +47.1% |
| Organon & Co. (OGN) | 2025-12-31 | $752.00M | +59.3% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.36B | +30.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.55B | +7.4% |
Compare VRTX, BHC, VTRS, REGN side by side · Screen every company in Pharmaceutical Preparations ↗